HomeInsights52 Week High Stocks

Zenith Drugs Ltd 52 Week High

Zenith Drugs Ltd 52 Week High

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Jan 14, 2025)

stocks purchased

8.0 K

Stocks Traded

(Jan 14, 2025)

Last Updated on: Jan 14, 2025

Image

Zenith Drugs Ltd

NSE: Zenith

YEARHIGH

₹ 154.4

Last updated on: Jan 14, 2025

Key Highlights

  • The 52 Week HIGH of Zenith Drugs Ltd is ₹ 154.4 as of 14 Jan 25 .

Company Fundamentals for Zenith Drugs Ltd

No data available

Market Price of Zenith Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Zenith Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 202593.55
13 Jan 202595.45
10 Jan 2025100.45
09 Jan 202596.35
08 Jan 202591.8
07 Jan 202587.45
06 Jan 202583.3
03 Jan 202583.3
02 Jan 202584.25
01 Jan 202583.1

Asset Value vs Market Value of Zenith Drugs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Zenith Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Zenith Drugs Ltd

No data available

* All values are in crore

Zenith Drugs Ltd News Hub

News

Zenith Drugs to table results

Zenith Drugs will hold a meeting of the Board of Directors of the Company on 14 November 2...

Read more

11 Nov 2024 15:10

News

Zenith Drugs to convene AGM

Zenith Drugs announced that the 24th Annual General Meeting (AGM) of the company will be h...

Read more

02 Sep 2024 10:55

News

Board of Zenith Drugs recommends final dividend

Zenith Drugs announced that the Board of Directors of the Company at its meeting held on 2...

Read more

30 May 2024 15:14

News

Zenith Drugs to discuss results

Zenith Drugs will hold a meeting of the Board of Directors of the Company on 29 May 2024. ...

Read more

24 May 2024 20:04

News

Zenith Drugs to convene board meeting

Zenith Drugs will hold a meeting of the Board of Directors of the Company on 17 July 2024....

Read more

15 Apr 2024 10:01

News

NSE SME Zenith Drugs kicks off successfully

The scrip was listed at Rs 110, a premium of 39.24% compared with the initial public offer...

Read more

27 Feb 2024 11:21

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Zenith Drugs Ltd

What is the significance of Zenith Drugs Ltd reaching its 52-week high?

Zenith Drugs Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Zenith Drugs Ltd 52-week high?

Investors monitor Zenith Drugs Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Zenith Drugs Ltd a good buy when it hits its 52-week high?

Whether Zenith Drugs Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Zenith Drugs Ltd fundamentals.

What should I consider before investing in Zenith Drugs Ltd at its 52-week high?

Before investing in Zenith Drugs Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Zenith Drugs Ltd stock price continue to rise after reaching its 52-week high?

Zenith Drugs Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions